COVID-19 Vaccination Updates & FAQs

The University of Vermont Health Network is proud to be working with local partners and the state of New York to distribute the COVID-19 vaccine.


Get Your COVID-19 Vaccine

Last Updated June 18, 2021

Vaccines are available for those 12 and older. 

Find a COVID-19 vaccine near you by searching on, texting your ZIP code to 438829 or calling 1-800-232-0233. You can also visit the New York Department of Health website to register.

COVID-19 Vaccine Frequently Asked Questions

This information has been developed by the UVM Health Network, based on the most up-to-date public health guidance, to respond to some of the common questions you may have relating to the vaccine and how it will be administered here.

Last Updated July 20, 2021

Getting Your Vaccine

As directed by the State of New York, all people ages 12+ are eligible for the COVID-19 vaccination as of Thursday, April 13. 


Search on, text your ZIP code to 438829, or call 1-800-232-0233.


Local pharmacies, including Costco, Walmart, CVS, Kinney Drugs and Walgreens are currently administering vaccination clinics. 


Appointments are being scheduled at New York State-operated vaccination locations. Use the  Am I Eligible? app to make an appointment, or call the New York State COVID-19 Vaccination Hotline at 1-833-NYS-4-VAX (1-833-697-4829).


More information available on County Health Department Sites:

Free transportation to vaccine clinics is available through each county’s Office of Aging. Please contact them directly to set up a ride.

  • Franklin County: 548-481-1526
  • Clinton County: 518-565-4620
  • Essex County: 518-873-3695

Seniors within Franklin County have two additional options for transportation:

  • Rides are available in Malone, Tupper Lake and Saranac Lake by calling 518-483-9000 at least 24 hours before your appointment.
  • Seniors with Medicaid can schedule transportation by calling Franklin County Medicaid Transportation: 888-262-3975.

Safety, Eligibility & Effectiveness

Yes. Vaccine safety and effectiveness is based on a standard and highly rigorous clinical trial assessment involving tens of thousands of volunteers. Although the current vaccines were developed more quickly than usual, they still went through the same process. The FDA approved the emergency use of vaccines developed by Pfizer, Moderna, and Johnson & Johnson, with other vaccines under review for use in the near future.

Yes. Because of the severe health risks of COVID-19 and the fact that you can get COVID-19 again, you should be vaccinated even if you have already had COVID-19.

The CDC recommends that people wait 90 days after recovering from COVID-19 before receiving the vaccine, except in cases of high-risk, including healthcare workers and those with high-risk conditions. In these cases, individuals should be symptom-free for 14 days before receiving the vaccine.

Yes. The COVID-19 vaccination is very important for people with underlying health problems like heart disease, lung disease, diabetes and obesity. People with these conditions are more likely to get very sick from COVID-19.

While the vaccines were not extensively studied in people with weakened immune systems, there is no reason to expect any safety concerns.

HIV and other conditions associated with a weakened immune system have been associated with higher risk of severe illness from COVID-19. Therefore, the Advisory Committee on Immunization Practices, which provides health care expertise on vaccines in the U.S., recommends vaccinating people with weakened immune systems.

Most people with food or medication allergies can receive a COVID-19 vaccine safely. However, if you have had a severe allergic reaction to a vaccine or a medication (requiring you to seek immediate medical care) in the past, it is important to discuss with your doctor before getting the vaccine.

Signs of a severe allergic reaction can include:

  • Hives or a rash
  • Difficulty breathing
  • Swelling of your face or throat
  • Anaphylaxis

Pregnant patients are more likely to have serious illness from COVID-19 and are at risk of developing pregnancy complications as a result. The vaccine is very effective in reducing the risk of infection. While pregnant and breastfeeding individuals were not included in COVID-19 vaccine studies, the American College of Obstetricians and Gynecologists recommends that individuals who are pregnant or breastfeeding be offered the vaccine to prevent serious illness. While there is still not enough information to specifically recommend the vaccine during pregnancy or breastfeeding, as of now, thousands of pregnant individuals have received the vaccine without known issue. If you are pregnant or breastfeeding, you should discuss the vaccine with your doctor so you can make the decision that is right for you.

The vaccine rollout plan in New York is determined by the state health department and is following CDC recommendations. These recommendations are designed to decrease death and serious disease as much as possible, preserve the functioning of society, and reduce the extra burden COVID-19 is having on people already facing disparities. 

At this time, our Radiology Department recommends that screening studies be done either prior to a patient receiving the COVID-19 vaccine or 4 to 6 weeks after. Lymph node swelling is a common side effect of the vaccine and can complicate the reading of a scan.

Because the vaccines have not yet been sufficiently studied in children, current recommendations are guided by age limits: The Pfizer COVID-19 vaccine may be administered to patients age 12 and above. The Moderna and Johnson & Johnson vaccines may be administered to patients 18 and older.

It is thought that the vaccines will still protect against severe disease caused by most of these viral variants, but this is a fast-moving area that scientists and public health professionals are watching very closely.

It is therefore important that infection prevention precautions continue according to national and state guidance.

For Cancer Patients

Cancer patients are at increased risk for severe COVID-19 and should get vaccinated once the vaccine is available to them, unless their physician advises otherwise or there are contraindications to the vaccine, such as a severe allergic reaction to a vaccine or medication in the past requiring you to seek immediate medical care. Cancer patients should discuss COVID-19 vaccination with their provider to understand the effectiveness of vaccines for those being treated for cancer and to discuss any contraindications.

In New York, adults with cancer, current or in remission, including 9/11-related cancers, became eligible for vaccination as of February 15, 2021.


Cancer patients are at increased risk for severe COVID-19 and should get vaccinated once the vaccine is available to them, unless their physician advises otherwise or there are contraindications to the vaccine, such as a severe allergic reaction to a vaccine or a medication in the past requiring you to seek immediate medical care. Cancer patients should discuss vaccination with their provider to discuss contraindications and to understand the effectiveness of vaccines for those being treated for cancer.

Recent COVID-19 vaccine trials did not include a large number of cancer patients. However, these vaccines do not contain live virus and non-live vaccines are generally considered safe - and are commonly recommended - for cancer patients.

Vaccine effectiveness may be reduced in cancer patients with suppressed immune systems as the ability to mount a response to the vaccine may be limited. Still, the benefit of vaccination is considered greater than the risk of not getting the vaccine, barring any contraindications.

After receiving the vaccine, it is advisable for cancer patients, like everyone, to continue following appropriate hygiene and safety protocols.

We do not recommend that patients delay cancer treatments to get vaccinated. However, a physician and patient may decide to hold off on treatment on a case-by-case basis depending on the urgency of treatment, the seriousness of illness, and the risk and benefit of delay.

Patients getting mammograms or CT scans may show enlarged lymph nodes after vaccination, a common physical response to the vaccine. These results may lead to further testing to rule out cancer as the cause. For this reason, if there is no urgent reason for immediate imaging, it is best to get these screening tests either prior to your COVID-19 vaccination or 4 to 6 weeks after vaccination.

After You Are Vaccinated

Yes, you should continue to follow local guidelines around masking even after you are vaccinated.

We know that the vaccine makes symptomatic disease less likely, reducing the risk of hospitalization and death, but we still don’t know if it prevents infection in the first place or prevents spreading the virus to others. Therefore it remains critical that we continue to follow all of the preventive guidelines outlined by the CDC, local departments of health and state government in Vermont and New York while vaccines are administered.

According to the CDC, the fit of your mask dictates how much protection in provides; the better the fit, the greater the protection. To get your mask to fit well, here are some tips:

Cloth Masks:

  • Look for cloth masks with a nose wire and adjustable ear loops or ties in order to improve the fit
  • Choose a cloth mask that is well-fitting and has at least two layers of fabric
  • It is not necessary to wear two well-fitting cloth masks

Disposable Masks:

  • Choose a disposable mask with three layers of material (3-ply)
  • Knot the ear loops and tuck in any extra material in order to get a snug fit (How-to video)
  • Wear a tight-fitting cloth mask over a disposable mask
  • Do not wear two disposable masks at once; it won’t help improve the fit

General Vaccine Information

No. None of the COVID-19 vaccines currently in development in the United States use the live virus, meaning that you can’t get COVID-19 from the vaccine. The vaccine teaches your immune systems how to recognize and fight the virus in the event you become exposed.

It is important to know that it typically takes a few weeks for the body to build immunity after vaccination. It is therefore possible to be infected just before or just after vaccination.

Most people experience some minor side effects after getting the COVID-19 vaccine. The most common side effects that have been reported include a sore arm at the injection site, fatigue, headache, chills and possibly a fever. These symptoms should go away on their own in a day or two.

No. While you may have some antibody protection after recovering from COVID-19, we don’t know how long this protection lasts – and you don’t want to risk getting the virus again. COVID-19 can cause serious illness, debilitating symptoms that persist for months and can result in death. Vaccination is your best protection, and it is safe.

Giving a second dose of a vaccine can boost immune response and improve the chances of protection from infection. The first two vaccines, Pfizer and Moderna, require two doses. The second dose of the Pfizer COVID-19 vaccine is given 21 days after the first, and the second dose of the Moderna vaccine is given 28 days after the first dose.

The Johnson & Johnson vaccine only requires one dose.

While there are a few days of leeway in timing for the second dose, it is important that you get your second shot as close to the recommended time as possible and not get the second dose any earlier.

Please talk to your doctor if you can’t get the second dose within a few days of the recommended dosage interval.

No. There is not enough data yet to say whether there are any risks of receiving the COVID-19 vaccine at the same time as other vaccines. You should wait at least 14 days after you get your COVID-19 vaccine to get any other vaccine, including a flu or shingles vaccine. If you get another vaccine first, wait at least 14 days before getting your COVID-19 vaccine.

The COVID-19 vaccine development process was accelerated in an effort to address the crisis of the global pandemic. One of the benefits of this worldwide focus is that multiple groups of scientists have been working simultaneously on vaccines. Ultimately, the goal is to have a safe and effective vaccine for every person, regardless of age, demographics or underlying medical conditions. By having multiple vaccines approved and manufactured, we are able to increase the number of doses available.

Vaccine Trials

More than 250 participants are enrolled in the AstraZeneca vaccination trial being conducted by the UVM Medical Center and UVM Larner College of Medicine. Learn more about the trial. While the vaccine has been approved for emergency use in the United Kingdom, it is still being studied and not yet available in the United States.

Multiple vaccines are in various stages of development, and clinical trials tell us how effective the vaccines are likely to be for different age groups and populations – and how long immunity will last. For several of the vaccines under development, we are still learning about their safety and efficacy, so it’s very important that the clinical trials continue throughout this process.